Figure 2
![Figure 2. Serum reactivity to GPIIIa49-66 mimicry peptide and thrombocytopenia in HCV, HIV, and HIV/HCV-ITP patients. Serum samples were collected from immunologic thrombocytopenia patients (15 HCV-ITP [A], 15 HIV-ITP [B], and 15 HIV/HCV-ITP intravenous drug abusers [C]). Serum reactivity to GPIIIa49-66 and its mimicry peptides HCV (PHC09, PHC09-H5, and PHC07) as well as HIV-1 peptide nef and irrelevant peptide (IR) was measured by ELISA with patient sera. SEM is given. Horizontal lines refer to 2 SDs. The severity of thrombocytopenia was evaluated by platelet count (D). Horizontal bar is an arbitrary 30 × 109/L cut-off.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/113/17/10.1182_blood-2008-09-181073/4/zh80060930850002.jpeg?Expires=1742743633&Signature=4PbizkYA1Bfv9tyoY1YPcjpgyux1TNcc-8joezdH0NnEA3336Rt6z7oPCu~kSDYBHKuMTcVopF~iPf2pBYQRIR~V7cQ0XTes0mb9KW6TQOm~Ik~GrKV-s0gcbGONriMQXIH6O5hE-UJ3jwFuL6ixTrSFe~0kOOiUIKhFjcq1I4wavCYQ37l2RweoT1l65AAqaCh5iH8MV7TBu68F8bQO3BjOn5CgLf3IM9v6AKZDpb7W5bX6zlf8Qeob3e5nxZS9eOwamLpbs~8AQGYTKK8yBy9TDzCfenznEJzIBUjOx~-~Xgp2dp7MqpoG71QOese06NWHuLyzYIjThpO2WILsSg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Serum reactivity to GPIIIa49-66 mimicry peptide and thrombocytopenia in HCV, HIV, and HIV/HCV-ITP patients. Serum samples were collected from immunologic thrombocytopenia patients (15 HCV-ITP [A], 15 HIV-ITP [B], and 15 HIV/HCV-ITP intravenous drug abusers [C]). Serum reactivity to GPIIIa49-66 and its mimicry peptides HCV (PHC09, PHC09-H5, and PHC07) as well as HIV-1 peptide nef and irrelevant peptide (IR) was measured by ELISA with patient sera. SEM is given. Horizontal lines refer to 2 SDs. The severity of thrombocytopenia was evaluated by platelet count (D). Horizontal bar is an arbitrary 30 × 109/L cut-off.
